2000
DOI: 10.7326/0003-4819-133-6-200009190-00019
|View full text |Cite
|
Sign up to set email alerts
|

Under Toad Days: Surviving the Uncertainty of Cancer Recurrence

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
50
0

Year Published

2005
2005
2018
2018

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 47 publications
(50 citation statements)
references
References 0 publications
0
50
0
Order By: Relevance
“…Instead, mean distress scores declined, and the decline was significant for intrusive thoughts. These results are perplexing given the multitude of personal anecdotes (Mullan, 1985;McKinley, 2000), clinical observations (Rowland and Holland, 1990;Schnipper, 2001), and information collected via structured interview (Ward et al, 1992;Beisecker et al, 1997), suggesting that the post-treatment period is marked by distress, anxiety, transition, and disruption. However, results are consistent with a previous empirical investigation of breast cancer survivors (Deshields et al, 2005).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Instead, mean distress scores declined, and the decline was significant for intrusive thoughts. These results are perplexing given the multitude of personal anecdotes (Mullan, 1985;McKinley, 2000), clinical observations (Rowland and Holland, 1990;Schnipper, 2001), and information collected via structured interview (Ward et al, 1992;Beisecker et al, 1997), suggesting that the post-treatment period is marked by distress, anxiety, transition, and disruption. However, results are consistent with a previous empirical investigation of breast cancer survivors (Deshields et al, 2005).…”
Section: Discussionmentioning
confidence: 99%
“…The completion of adjuvant treatment (chemotherapy and/or radiation therapy) may be one such period. Case studies and other anecdotal evidence in the literature suggest that the months immediately following the end of adjuvant treatment is a time of disruption, transition, and increased distress (Ward et al, 1992;Lethborg et al, 2000;McKinley, 2000;Schnipper, 2001).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Twenty years ago, Dr. Fitzhugh Mullan, Chief Medical Officer of the Office of Medical Applications of Research at the National Institutes of Health, wrote about his own experience with cancer and what he called the "reentry" phase. 10,11 The themes Dr. Mullan described in his process of the resumption of life as an active adult 10 are remarkably similar to those that were identified by other cancer survivors, 12,13 healthcare professionals, 9,[12][13][14][15] and qualitative researchers 16 -19 over the next 2 decades. An important point made by those writers was that the challenges faced during reentry often are unanticipated and leave the individual feeling ill-prepared to manage them.…”
Section: The Adaptive Tasks Of Reentrymentioning
confidence: 93%
“…An important point made by those writers was that the challenges faced during reentry often are unanticipated and leave the individual feeling ill-prepared to manage them. 12 Instead of being able to predict the challenges, many patients and their intimate others hold expectancies that we may describe as the "myths of treatment completion" (see Table 1). …”
Section: The Adaptive Tasks Of Reentrymentioning
confidence: 99%